Lv1
60 积分 2023-03-20 加入
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
3个月前
已完结
Pseudoprogression on 68Ga-DOTATATE PET/CT in a Pediatric Patient With Neuroblastoma
3个月前
已完结
Recent developments in olfactory neuroblastoma research
3个月前
已完结
Antibody‐Dependent Cellular Cytotoxicity of iPS Cell‐Derived Natural Killer T Cells by Anti‐GD2 mAb for Neuroblastoma
3个月前
已完结
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
3个月前
已完结
Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
3个月前
已完结
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial
3个月前
已完结
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial
3个月前
已完结
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma
3个月前
已完结
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma
3个月前
已完结
皖公网安备34019202002308
